Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: Implications for intraoperative specimen evaluation

被引:9
|
作者
Rabban, Joseph T. [1 ]
Mackey, Amber [1 ]
Powell, C. Bethan [2 ]
Crawford, Beth [3 ]
Zaloudek, Charles J. [1 ]
Chen, Lee-may [2 ]
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94313 USA
[2] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94313 USA
[3] UCSF Helen Diller Family Comprehens Canc Ctr, Canc Risk Program, San Francisco, CA USA
关键词
Risk-reducing salpingo-oophorectomy; Intraoperative evaluation; Occult carcinoma; BRCA; Fallopian tube; FALLOPIAN-TUBE; PROPHYLACTIC OOPHORECTOMY; MUTATION CARRIERS; FROZEN-SECTION; FORMALIN FIXATION; BRCA MUTATIONS; OVARIAN-TUMORS; BREAST-CANCER; WOMEN; CARCINOMA;
D O I
10.1016/j.ygyno.2011.01.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. A minority of risk-reducing salpingo-oophorectomy (RRSO) specimens from BRCA mutation carriers will contain clinically occult carcinoma that is detectable only using a specialized pathologic evaluation protocol. Although intraoperative detection of cancer may alter immediate surgical management, technical complications impairing pathologic diagnosis may result if fresh tissue dissection and frozen sections are performed on unselected RRSO specimens. We hypothesize that macroscopic specimen findings may predict which RRSO specimens contain cancer and therefore may guide selection of specimens for intraoperative pathologic evaluation. The aim of this study was to correlate the macroscopic and microscopic pathologic findings in RRSO. Methods. RRSO specimens from 134 women with a BRCA mutation were retrospectively classified by their grossly visible findings (cysts and/or nodules versus grossly unremarkable). Correlation of the gross findings with the microscopic finding of occult tubal and/or ovarian carcinoma was performed by re-examination of all pathology slides. Results. While 46% of RRSO had visible ovarian cysts and 34% had visible tubal/paratubal cysts, no cyst contained cancer on microscopic examination. Carcinoma was detected in 2/22 (9%) visible ovarian nodules and in 2/8 (25%) visible tubal nodules. Conversely, among all 11 RRSO specimens containing cancer, 7 (64%) had no corresponding visible abnormality. Conclusion. Frozen section evaluation of a solid nodule may be valuable in patients consented for immediate surgical staging. Otherwise it is best to avoid intraoperative dissection or frozen section of RRSO that are macroscopically normal or contain only cysts; such specimens should remain undissected for immediate formalin-fixation as the first step of the specialized pathology evaluation protocol. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:466 / 471
页数:6
相关论文
共 50 条
  • [1] Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty
    Malacarne, Dominique R.
    Boyd, Leslie R.
    Long, Yang
    Blank, Stephanie V.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [2] The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy
    Miller, Heather
    Pipkin, Laura S.
    Tung, Celestine
    Hall, Tracilyn R.
    Masand, Ramya P.
    Anderson, Matthew L.
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2017, 24 (05) : 772 - 776
  • [3] Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?
    Cass, Ilana
    Walts, Ann
    Karlan, Beth Y.
    GYNECOLOGIC ONCOLOGY, 2010, 117 (01) : 27 - 31
  • [4] Effectiveness of Risk-Reducing Salpingo-Oophorectomy in Preventing Ovarian Cancer in a High-Risk French Canadian Population
    Bacha, Omar Moreira
    Gregoire, Jean
    Grondin, Katherine
    Edelweiss, Maria Isabel
    Laframboise, Rachel
    Simard, Jacques
    Plante, Marie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (06) : 974 - 978
  • [5] Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy
    Tucker, Paige E.
    Bulsara, Max K.
    Salfinger, Stuart G.
    Tan, Jason Jit-Sun
    Green, Helena
    Cohen, Paul A.
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 95 - 100
  • [6] Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy
    Tucker, Paige E.
    Cohen, Paul A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (04) : 847 - 852
  • [7] Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers
    Rhiem, Kerstin
    Foth, Dolores
    Wappenschmidt, Barbara
    Gevensleben, Heidrun
    Buettner, Reinhard
    Ulrich, Uwe
    Schmutzler, Rita K.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (03) : 623 - 627
  • [8] Impact of risk-reducing salpingo-oophorectomy in premenopausal women
    Vermeulen, R. F. M.
    van Beurden, M.
    Korse, C. M.
    Kenter, G. G.
    CLIMACTERIC, 2017, 20 (03) : 212 - 221
  • [9] Risk reducing salpingo-oophorectomy for BRCA mutation carriers: Twenty years later
    Powell, C. Bethan
    GYNECOLOGIC ONCOLOGY, 2014, 132 (02) : 261 - 263
  • [10] Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens
    Reitsma, Welmoed
    de Bock, Geertruida H.
    Oosterwijk, Jan C.
    Bart, Joost
    Hollema, Harry
    Mourits, Marian J. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (01) : 132 - 141